Long-term iron supplementation in four patients with X-linked erythropoietic protoporphyria: associations with serum proteins and erythrocyte protoporphyrin levels—a single-centre retrospective study
However, monitoring for adequate dosing and long-term effects is advisable and a standardisation of treatment protocols and international best practice guidelines are needed.
Authors
- Elisabeth I. Minder (ORCID: https://orcid.org/0000-0002-1689-2256)
- Francesca Granata (ORCID: https://orcid.org/0000-0002-6939-1009)
- Lanja Saleh (ORCID: https://orcid.org/0000-0003-3364-7954)
- Jasmin Barman‐Aksözen (ORCID: https://orcid.org/0000-0001-7272-8824)
- Franziska van Breemen
- Xiaoye Schneider‐Yin
- Anna-Elisabeth Minder
Institutions
- University of Zurich (CH)
- Triemli Hospital (CH)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- University Children's Hospital Zurich (CH)
- Swiss Re (Switzerland) (CH)
Publication Details
- Journal
- Frontiers in Molecular Biosciences
- Published
- 2025-02-13
- DOI
- https://doi.org/10.3389/fmolb.2025.1509803
- Citations
- 2
- Primary Topic
- Porphyrin Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.61